related content
Moderna vaccine profits channelled to tax havens
Vaccine manufacturer Moderna is employing tax avoidance structures to shift its profits to Switzerland and the US state of Delaware, research by SOMO in cooperation with Wemos. The European Union ordered $10.3 billion worth of…
Moderna’s free ride
Pocketing tax free profits from publicly funded jabs
How can we make publicly funded corona vaccines accessible to all?
Global vaccine scarcity unnecessary if pharma shares knowledge
In a joint letter, SOMO together with 53 civil society organisations are calling upon the Dutch government to ensure that pharmaceutical companies share their knowledge of vaccine development with other companies in an existing pool…
Response of SOMO and Wemos to Government reaction on report ‘Overpriced’
On 27 August 2020, the Dutch Ministry of Economic Affairs responded in a letter to the Parliament to the SOMO report ‘Overpriced: drugs developed with Dutch Public Funding‘. On our Dutch website you find a…
New research reveals large-scale tax avoidance by coronavirus test manufacturer Qiagen
New research by the Centre for Research on Multinational Corporations (SOMO) shows that the German coronavirus test producer Qiagen has been able to dodge millions of euros in tax since 2010 thanks to tax avoidance…
Profiting from a pandemic
How COVID-19 test kit producer Qiagen receives public money but avoids taxes
Dutch parliament supports resolution on affordable and accessible corona vaccines
Webinar on public investment in medicines in Europe
The European Alliance for Responsible R&D and Affordable medicines organised in cooperation with Wemos, SOMO, Salud por Derecho, StopAids and Global Justice Now a webinar on public investments in biomedical research and development (R&D). The…